Inicio › Linfoma de Burkitt › Virginia

Ensayos clínicos de Linfoma de Burkitt en Virginia

7 estudios sobre Linfoma de Burkitt buscan participantes en Virginia.

Ciudades en Virginia

Texto oficial del estudio (inglés)

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

VCU Massey Comprehensive Cancer Center, Richmond

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT03739814

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

University of Virginia Cancer Center, Charlottesville
Inova Fairfax Hospital, Falls Church
Children's Hospital of The King's Daughters, Norfolk
y 2 más

ReclutandoFase 2

366 Days – 46 Years · Todos los sexos · Actualizado el 28 sept 2026 · NCT06124157

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

University of Virginia Cancer Center, Charlottesville
Children's Hospital of The King's Daughters, Norfolk
VCU Massey Comprehensive Cancer Center, Richmond
y 1 más

ReclutandoFase 2

365 Days · Todos los sexos · Actualizado el 25 sept 2026 · NCT06317662

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

VCU Massey Comprehensive Cancer Center, Richmond

ReclutandoFase 3

Edades de 18 a 39 · Todos los sexos · Actualizado el 2 sept 2026 · NCT03150693

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Inova Fairfax Hospital, Falls Church
Children's Hospital of The King's Daughters, Norfolk
VCU Massey Comprehensive Cancer Center, Richmond

ReclutandoFase 2

Edades de 1 a 30 · Todos los sexos · Actualizado el 1 sept 2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

University of Virginia Cancer Center, Charlottesville
Inova Fairfax Hospital, Falls Church
Children's Hospital of The King's Daughters, Norfolk
y 3 más

ReclutandoFase 3

365 Days – 25 Years · Todos los sexos · Actualizado el 25 ago 2026 · NCT03959085

AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia

Research Site, Richmond

ReclutandoFase 1/2

Edades de 12 en adelante · Todos los sexos · Actualizado el 19 ago 2026 · NCT06137118

De ClinicalTrials.gov, datos obtenidos el 1 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.